US Activist Hedge Fund Institutional SEC 13D 13G — October 05, 2026

05-10-2026

Ascent Partners Fund LLC and related entities filed an exit Schedule 13G/A with the SEC on October 5, 2026, reporting that as of August 27, 2026, they exercised all warrants to purchase and sold all remaining shares of C3is Inc. common stock. Consequently, the reporting persons now beneficially own zero shares of C3is Inc., representing a complete exit from their investment.

• · The exit filing covers nine reporting persons including Ascent Partners Fund LLC, Ascent Partners LLC, Dominion Capital LLC, Dominion Capital GP LLC, Eagle Claw Corp., Masada Group Holdings LLC, Mikhail Gurevich, Gennadiy Gurevich, and Alon Brenner.
• · All warrants were exercised and all remaining common shares were sold as of August 27, 2026.
• · The filing is an amendment to a Schedule 13G originally filed on August 4, 2026.

05-10-2026

AdvisorShares Trust disclosed a 6.78% beneficial ownership stake in Psyence Biomedical Ltd. as of September 30, 2026, holding 258,538 common shares. The filing is a Schedule 13G submitted under Rule 13d-1(b), indicating passive investment intent without control influence. No other material changes or transactions were reported.

• · Filing date: October 5, 2026
• · Date of event determining ownership: September 30, 2026
• · Type of security: Common shares, without par value
• · CUSIP: 74449F407
• · AdvisorShares Trust is a Delaware statutory trust
• · Filer certifies shares were acquired in ordinary course of business, not to influence control

05-10-2026

AdvisorShares Trust filed a Schedule 13G/A disclosing beneficial ownership of 400,378 Class B Subordinate Voting Shares of Quantum Biopharma Ltd. as of September 30, 2026, representing a 4.95% stake. The shares are held in the ordinary course of business and not for changing or influencing control.

• · The filing is an amendment (Schedule 13G/A) filed on October 5, 2026.
• · AdvisorShares Trust is a Delaware statutory trust with business address in Bethesda, Maryland.
• · Quantum Biopharma Ltd. is incorporated in Ontario, Canada (A6), with former name FSD Pharma Inc. (changed March 27, 2019).
• · The shares are held under Rule 13d-1(b), indicating the filing is by an institutional investment manager.
• · Sole voting power and dispositive power are both 400,378 shares.
• · The filing certifies the shares were not acquired to change or influence control.

05-10-2026

Kornitzer Capital Management Inc. disclosed a 6.3% beneficial ownership stake in Landmark Bancorp Inc. (LARK) as of September 30, 2026, holding 385,130 shares of common stock. The filing is an amended Schedule 13G, indicating the position is held in the ordinary course of business and not for changing or influencing control of the issuer.

• · Kornitzer Capital Management is an investment advisor based in Mission, Kansas.
• · The filing is an amendment (SC 13G/A) filed on October 5, 2026.
• · The shares were acquired and are held in the ordinary course of business, not for changing or influencing control.

05-10-2026

BlackRock, Inc. filed an amended Schedule 13G disclosing beneficial ownership of 12,897,766 shares of Builders FirstSource, Inc. common stock, representing 12.0% of the total outstanding shares, as of September 30, 2026. The filing indicates that one of BlackRock's entities, iShares Core S&P Small-Cap ETF, individually holds more than 5% of Builders FirstSource's common stock. The filing is an amendment to a previous Schedule 13G and includes a power of attorney and list of reporting entities.

• · The filing is an amendment (SC 13G/A) to a prior Schedule 13G filing.
• · BlackRock, Inc. has sole voting power over 12,581,470 shares and sole dispositive power over 12,897,766 shares.
• · The filing was made pursuant to Rule 13d-1(b) under the Securities Exchange Act of 1934.
• · The filing includes a list of 13 BlackRock entities, with BlackRock Fund Advisors noted as beneficially owning 5% or greater of the reported security class.
• · The power of attorney attached to the filing is dated January 21, 2025, and revokes a prior power of attorney dated April 30, 2023.

05-10-2026

BlackRock, Inc. filed a Schedule 13G/A with the SEC disclosing beneficial ownership of 2,419,163 shares of Matthews International Corporation Class A Stock as of September 30, 2026, representing a 7.8% stake. The filing indicates BlackRock's holdings are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

• · BlackRock has sole voting power over 2,372,267 shares and sole dispositive power over all 2,419,163 shares.
• · No single person within BlackRock's reporting group has an interest exceeding 5% of the total outstanding common shares.
• · The filing is an amendment to a previous Schedule 13G, reflecting updated ownership as of September 30, 2026.
• · BlackRock certifies the securities were acquired and are held in the ordinary course of business, not for control purposes.

05-10-2026

BlackRock, Inc. filed an amended Schedule 13G with the SEC on October 5, 2026, disclosing beneficial ownership of 7,460,672 shares of Innovex International, Inc. common stock, representing 10.7% of the outstanding shares. The filing indicates the shares are held in the ordinary course of business and not for the purpose of changing or influencing control of the company. This is a routine disclosure of passive investment by a major institutional shareholder.

• · BlackRock Fund Advisors is the entity that beneficially owns 5% or greater of the outstanding shares.
• · The filing is made pursuant to Rule 13d-1(b) under the Securities Exchange Act of 1934.
• · The filing includes a power of attorney dated January 21, 2025, appointing several attorneys-in-fact for BlackRock, Inc.

05-10-2026

BlackRock, Inc. filed an amended Schedule 13G with the SEC on October 5, 2026, reporting beneficial ownership of 10,395,973 shares of Century Aluminum Co common stock, representing 10.5% of the outstanding shares. The filing indicates that BlackRock Fund Advisors is the entity that beneficially owns 5% or more of the shares, and the securities are held in the ordinary course of business without the purpose of changing or influencing control of the company.

• · The filing is an amendment to a previous Schedule 13G, indicating a change in BlackRock's ownership stake.
• · BlackRock Fund Advisors is the entity that beneficially owns 5% or greater of the outstanding shares.
• · The filing includes a power of attorney dated January 21, 2025, appointing several attorneys-in-fact for BlackRock, Inc.
• · The securities are held in the ordinary course of business and not with the purpose of changing or influencing control of the issuer.

05-10-2026

BlackRock, Inc. filed a Schedule 13G/A with the SEC on October 5, 2026, disclosing beneficial ownership of 51,451,481 shares of Toast, Inc. Class A common stock as of September 30, 2026, representing 10.0% of the outstanding shares. The filing reflects a passive investment held in the ordinary course of business, with no intent to change or influence control of Toast. BlackRock Fund Advisors is the entity within the group that beneficially owns 5% or more of the class.

• · The filing is an amendment (13G/A) to a previous Schedule 13G, indicating a change in ownership or other required update.
• · BlackRock disclaims beneficial ownership of securities held by other business units not included in this filing, per SEC Release No. 34-39538.
• · No single person within the BlackRock group has an interest exceeding 5% of the total outstanding common shares.
• · The filing includes a Power of Attorney dated January 21, 2025, authorizing multiple individuals to execute ownership reports on behalf of BlackRock.

05-10-2026

BlackRock, Inc. filed an amended Schedule 13G with the SEC on October 5, 2026, disclosing beneficial ownership of 6,640,299 shares of DICK'S Sporting Goods, Inc. common stock, representing 10.2% of the outstanding shares. The filing indicates that BlackRock's holdings are held in the ordinary course of business and not for the purpose of changing or influencing control of the company. This is a routine disclosure of passive investment activity, with no change in control or strategic intent indicated.

• · BlackRock Fund Advisors is the entity that beneficially owns 5% or greater of the outstanding shares of the security class being reported.
• · The filing includes a Power of Attorney dated January 21, 2025, appointing several attorneys-in-fact for regulatory filings.
• · The filing is made pursuant to Rule 13d-1(b) under the Securities Exchange Act of 1934.

05-10-2026

BlackRock, Inc. filed an amended Schedule 13G disclosing beneficial ownership of 23,530,373 shares of Alignment Healthcare, Inc. common stock, representing 11.3% of the outstanding shares as of September 30, 2026. The filing indicates a slight decrease in share count from a prior base of 23,225,544 shares, though the percentage ownership remained at 11.3%. BlackRock states the shares were acquired in the ordinary course of business and not with the intent to influence control.

• · BlackRock Fund Advisors is the only entity within the BlackRock group that beneficially owns 5% or greater of the outstanding shares individually.
• · The filing includes a power of attorney dated January 21, 2025, authorizing multiple individuals to execute regulatory filings on behalf of BlackRock.
• · The filing is an amendment (SC 13G/A) to a prior Schedule 13G, indicating an ongoing reporting obligation.

05-10-2026

BlackRock, Inc. filed a Schedule 13G/A with the SEC on October 5, 2026, disclosing beneficial ownership of 48,984,658 Class A shares of Trade Desk, Inc., representing 11.4% of the outstanding stock. The filing is an amendment to a prior 13G and reflects holdings as of September 30, 2026. BlackRock's ownership increased from 48,046,402 shares (prior filing) to 48,984,658 shares, a gain of 938,256 shares, though the percentage change is not explicitly stated.

• · The filing is an amendment (13G/A) filed under Rule 13d-1(b), indicating passive investment intent.
• · BlackRock certifies the shares were acquired and held in the ordinary course of business, not to change or influence control.
• · One of BlackRock's subsidiaries, iShares Core S&P Small-Cap ETF, beneficially owns more than 5% of Trade Desk's outstanding common stock.
• · The filing includes a Power of Attorney dated January 21, 2025, authorizing multiple individuals to execute ownership reporting documents.
• · BlackRock's ownership increased by approximately 938,256 shares from the prior filing, a 1.95% increase in share count.

05-10-2026

BlackRock, Inc. filed a Schedule 13G/A with the SEC on October 5, 2026, disclosing beneficial ownership of 5,754,574 shares of SmartStop Self Storage REIT, Inc. common stock, representing 10.4% of the outstanding shares. The filing is an amendment to a previous Schedule 13G and reflects holdings acquired in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.

• · The filing is an amendment (Schedule 13G/A) filed under Rule 13d-1(b) by BlackRock, Inc.
• · BlackRock, Inc. is a Delaware corporation with its business address at 50 Hudson Yards, New York, NY 10001.
• · The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
• · No single person's interest in the common stock exceeds 5% of the total outstanding shares.
• · The filing includes a Power of Attorney dated January 21, 2025, appointing multiple attorneys-in-fact for reporting compliance.
• · Exhibit 99 lists 14 BlackRock entities, some of which beneficially own 5% or more of the outstanding shares.

05-10-2026

BlackRock, Inc. filed a Schedule 13G/A with the SEC on October 5, 2026, disclosing beneficial ownership of 12,015,098 shares of Verra Mobility Corp Class A common stock, representing 7.9% of the outstanding shares. The filing indicates BlackRock's holdings increased from 11,768,275 shares (7.9%) as of the prior filing, reflecting a net addition of 246,823 shares, though the ownership percentage remained flat at 7.9%.

• · The filing is an amendment (13G/A) to a previous Schedule 13G, indicating a change in beneficial ownership.
• · BlackRock's beneficial ownership increased by 246,823 shares (from 11,768,275 to 12,015,098), a 2.1% increase in share count.
• · Despite the increase in shares, the ownership percentage remained unchanged at 7.9% of the outstanding Class A common stock.
• · The filing includes a power of attorney dated January 21, 2025, authorizing multiple individuals to execute ownership reporting documents on behalf of BlackRock.
• · The filing lists 14 BlackRock entities that may beneficially own 5% or more of the security class, including BlackRock Advisors, LLC and BlackRock Fund Advisors.

05-10-2026

BlackRock, Inc. filed a Schedule 13G/A with the SEC on October 5, 2026, disclosing beneficial ownership of 38,673,303 shares of LifeStance Health Group, Inc. common stock, representing 10.1% of the outstanding shares. The filing indicates that BlackRock's holdings increased from the prior period, though the exact prior percentage is not provided in this filing.

• · BlackRock's beneficial ownership includes shares held by multiple subsidiaries, with BlackRock Fund Advisors owning 5% or more of the class.
• · The filing is made under Rule 13d-1(b), indicating passive investment intent.
• · No single person's interest in the common stock exceeds 5% of the total outstanding shares.
• · The filing certifies that the securities were acquired and are held in the ordinary course of business, not for changing or influencing control.

05-10-2026

BlackRock Inc. filed an amended Schedule 13G with the SEC on October 5, 2026, disclosing beneficial ownership of 12,222,382 shares of PBF Energy Inc. Class A common stock, representing 10.3% of the outstanding shares. The filing indicates that BlackRock acquired and holds the shares in the ordinary course of business, without the purpose of changing or influencing control of the issuer.

• · The filing is an amendment (13G/A) to a previous Schedule 13G.
• · BlackRock's beneficial ownership includes shares held by multiple subsidiaries, with BlackRock Fund Advisors beneficially owning 5% or greater of the class.
• · No single person's interest in the common stock exceeds 5% of the total outstanding shares.
• · The filing includes a Power of Attorney dated January 21, 2025, authorizing certain individuals to execute ownership reporting documents.

05-10-2026

BlackRock, Inc. filed an amended Schedule 13G with the SEC on October 5, 2026, disclosing beneficial ownership of 17,751,435 shares of Arcutis Biotherapeutics, Inc. common stock, representing 14.1% of the outstanding shares. The filing indicates that BlackRock's holdings increased from the prior period, with 17,576,492 shares having sole voting power and the same total amount having sole dispositive power. The filing notes that one of BlackRock's business units, iShares Core S&P Small-Cap ETF, individually holds more than 5% of the outstanding common stock.

• · The filing is an amendment to a prior Schedule 13G, indicating a change in BlackRock's ownership position.
• · BlackRock certifies the securities were acquired and held in the ordinary course of business, not for changing or influencing control of the issuer.
• · The filing includes a Power of Attorney dated January 21, 2025, authorizing multiple individuals to execute ownership reporting documents on behalf of BlackRock.
• · The filing lists 14 BlackRock business units that may be deemed to beneficially own the securities, with BlackRock Fund Advisors specifically noted as owning 5% or greater of the outstanding shares.

05-10-2026

BlackRock, Inc. filed a Schedule 13G with the SEC on October 5, 2026, disclosing beneficial ownership of 14,653,261 shares of Karman Holdings Inc. common stock, representing 11.1% of the outstanding shares. The filing indicates the shares are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer. The interest is primarily held through BlackRock Fund Advisors, which beneficially owns 5% or more of the outstanding shares.

• · The filing is made pursuant to Rule 13d-1(b) under the Securities Exchange Act of 1934.
• · BlackRock's beneficial ownership is reported as of September 30, 2026.
• · The filing includes a power of attorney dated January 21, 2025, appointing several attorneys-in-fact.
• · The interest of iShares Core S&P Small-Cap ETF in Karman Holdings Inc. is more than five percent of the total outstanding common stock.
• · BlackRock Fund Advisors is the entity that beneficially owns 5% or greater of the outstanding shares.

05-10-2026

BlackRock, Inc. filed a Schedule 13G/A with the SEC on October 5, 2026, disclosing beneficial ownership of 18,415,622 shares of Molson Coors Beverage Co Class B Stock, representing 10.6% of the outstanding shares as of September 30, 2026. The filing reflects a slight decrease in BlackRock's holdings from the prior period, with 17,937,926 shares having sole voting power and 18,415,622 shares having sole dispositive power. One of BlackRock's subsidiaries, iShares Core S&P Small-Cap ETF, individually holds more than 5% of the outstanding common stock.

• · The filing is an amendment to a previous Schedule 13G, indicating a change in BlackRock's holdings.
• · BlackRock's sole voting power decreased to 17,937,926 shares from a prior undisclosed amount.
• · The filing certifies that the securities were acquired and held in the ordinary course of business, not for changing or influencing control of the issuer.
• · A power of attorney dated January 21, 2025, authorizes multiple individuals to execute filings on behalf of BlackRock.

05-10-2026

BlackRock, Inc. filed a Schedule 13G/A with the SEC on October 5, 2026, disclosing beneficial ownership of 9,071,872 shares of Delek US Holdings, Inc. common stock, representing 14.8% of the outstanding shares. The filing is an amendment to a previous 13G and reflects BlackRock's passive investment in the company, with the shares held in the ordinary course of business and not for the purpose of changing or influencing control.

• · The filing is an amendment (Schedule 13G/A) filed under Rule 13d-1(b), indicating passive investment intent.
• · BlackRock has sole voting power over 8,978,510 shares and sole dispositive power over 9,071,872 shares.
• · The iShares Core S&P Small-Cap ETF, a BlackRock-managed fund, individually holds more than 5% of Delek's outstanding common stock.
• · BlackRock's beneficial ownership is aggregated across multiple reporting business units, as permitted under SEC Release No. 34-39538.
• · The filing includes a Power of Attorney (Exhibit 24) dated January 21, 2025, and a list of subsidiaries (Exhibit 99) that may hold shares.

05-10-2026

BlackRock, Inc. filed an amended Schedule 13G with the SEC disclosing beneficial ownership of 2,053,004 shares of NexPoint Residential Trust, Inc. (NXRT) common stock as of September 30, 2026, representing an 8.0% stake. The filing indicates the shares were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.

• · BlackRock holds sole voting power over 2,011,238 shares and sole dispositive power over 2,053,004 shares.
• · No single person within BlackRock's reporting group has an interest exceeding 5% of the outstanding common shares.
• · The filing is an amendment to a prior Schedule 13G, reflecting ownership as of September 30, 2026.
• · BlackRock certifies the securities were acquired and are held in the ordinary course of business, not to change or influence control.

05-10-2026

BlackRock, Inc. filed an amended Schedule 13G with the SEC on October 5, 2026, disclosing beneficial ownership of 5,198,586 shares of HubSpot Inc. common stock, representing 10.4% of the outstanding shares as of September 30, 2026. The filing indicates that BlackRock's holdings are held in the ordinary course of business and not for the purpose of changing or influencing control of HubSpot. The ownership is spread across multiple BlackRock entities, with BlackRock Fund Advisors being the only entity owning 5% or more of the class.

• · BlackRock Fund Advisors is the only entity within BlackRock that beneficially owns 5% or more of the outstanding shares of HubSpot Inc. common stock.
• · The filing is an amendment to a prior Schedule 13G, indicating a change in BlackRock's ownership position.
• · BlackRock's ownership is held in the ordinary course of business and not for the purpose of changing or influencing control of HubSpot Inc.

05-10-2026

BlackRock, Inc. filed an amended Schedule 13G with the SEC, disclosing beneficial ownership of 8,164,777 shares of Franklin BSP Realty Trust, Inc. common stock, representing 9.8% of the outstanding shares as of September 30, 2026. The filing indicates the shares are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer. BlackRock Fund Advisors is the only business unit that beneficially owns 5% or more of the outstanding shares.

• · BlackRock Fund Advisors is the only BlackRock business unit that beneficially owns 5% or more of the outstanding shares of Franklin BSP Realty Trust, Inc.
• · The filing is made pursuant to Rule 13d-1(b) under the Securities Exchange Act of 1934.
• · The Schedule 13G/A was filed on October 5, 2026, with an event date of September 30, 2026.
• · BlackRock, Inc. is incorporated in Delaware and has its principal business address at 50 Hudson Yards, New York, NY 10001.
• · The filing includes a power of attorney dated January 21, 2025, revoking a prior power of attorney dated April 30, 2023.

05-10-2026

BlackRock, Inc. filed a Schedule 13G/A with the SEC on October 5, 2026, disclosing beneficial ownership of 7,325,596 shares of iShares MSCI India ETF (Common Stock), representing 5.9% of the outstanding shares. The filing is an amendment to a previous 13G and was made pursuant to Rule 13d-1(b), indicating the shares were acquired in the ordinary course of business and not to influence control.

• · The filing is an amendment (Schedule 13G/A) to a prior 13G filing.
• · BlackRock's beneficial ownership includes shares held by certain business units, excluding others per SEC Release No. 34-39538.
• · No single person's interest in the common stock exceeds 5% of the total outstanding shares.
• · The filing includes a Power of Attorney dated January 21, 2025, authorizing multiple individuals to execute reporting documents.
• · Entities with 5% or greater beneficial ownership include BlackRock Investment Management (Australia) Limited, BlackRock Asset Management North Asia Limited, and BlackRock Institutional Trust Company, National Association.

05-10-2026

BlackRock, Inc. filed an amended Schedule 13G with the SEC on October 5, 2026, disclosing beneficial ownership of 9,359,639 shares of AXT Inc. common stock, representing 14.3% of the outstanding shares. The filing indicates that BlackRock's holdings increased from 9,254,836 shares (as of the prior filing) to 9,359,639 shares, a net increase of 104,803 shares. The filing also notes that one of BlackRock's subsidiaries, iShares Core S&P Small-Cap ETF, holds more than 5% of AXT's outstanding common stock.

• · The filing is an amendment to a previous Schedule 13G, indicating ongoing monitoring of ownership.
• · BlackRock's ownership increased by approximately 1.13% from the prior filing (from 9,254,836 to 9,359,639 shares).
• · The filing includes a list of 14 subsidiaries of BlackRock that may hold or manage the shares, with BlackRock Fund Advisors specifically noted as beneficially owning 5% or more of the class.
• · The filing certifies that the securities were acquired and held in the ordinary course of business, not with the purpose of changing or influencing control of AXT Inc.

05-10-2026

BlackRock, Inc. filed an amended Schedule 13G with the SEC on October 5, 2026, reporting beneficial ownership of 3,932,477 shares of Cogent Communications Holdings, Inc. common stock, representing 7.7% of the outstanding shares as of September 30, 2026. The filing reflects a decrease from the prior reported 3,858,290 shares (7.6%), indicating a slight increase in BlackRock's stake. The shares are held in the ordinary course of business, with no intent to influence control.

• · BlackRock's beneficial ownership increased by 74,187 shares (from 3,858,290 to 3,932,477) between the prior filing and September 30, 2026.
• · The filing is made pursuant to Rule 13d-1(b), indicating passive investment intent.
• · No single person's interest in the common stock exceeds 5% of the total outstanding shares.
• · BlackRock has appointed multiple attorneys-in-fact for filing ownership reports, effective January 21, 2025.

05-10-2026

BlackRock, Inc. filed an amended Schedule 13G with the SEC on October 5, 2026, disclosing beneficial ownership of 13,579,859 shares of WesBanco Inc. common stock, representing 14.2% of the outstanding shares. The filing indicates that BlackRock's ownership increased from the prior period, though the exact prior percentage is not provided in this filing. The shares are held in the ordinary course of business and not for control purposes.

• · The filing is an amendment to a prior Schedule 13G, indicating a change in BlackRock's ownership.
• · BlackRock's sole voting power covers 13,422,205 shares, while sole dispositive power covers all 13,579,859 shares.
• · The iShares Core S&P Small-Cap ETF, a BlackRock fund, holds more than 5% of WesBanco's outstanding common stock.
• · The filing includes a Power of Attorney dated January 21, 2025, authorizing multiple individuals to execute ownership reports on behalf of BlackRock.
• · BlackRock Fund Advisors is identified as the entity that beneficially owns 5% or more of the reported security class.

05-10-2026

BlackRock, Inc. filed an amended Schedule 13G with the SEC on October 5, 2026, reporting beneficial ownership of 3,810,952 shares of Shenandoah Telecommunications Co. common stock, representing 6.9% of the outstanding shares. The filing indicates BlackRock's holdings increased from 3,731,060 shares (prior period) to 3,810,952 shares, a 2.1% increase in share count, while the ownership percentage remained flat at 6.9%.

• · The filing is made under Rule 13d-1(b), indicating passive investment intent.
• · BlackRock certifies the shares were acquired and are held in the ordinary course of business, not to change or influence control of the issuer.
• · No single person within BlackRock's reporting group beneficially owns more than 5% of the outstanding common shares.
• · The filing includes a power of attorney dated January 21, 2025, authorizing multiple individuals to execute ownership reporting documents.

05-10-2026

BlackRock, Inc. filed a Schedule 13G/A with the SEC on October 5, 2026, disclosing beneficial ownership of 4,675,626 shares of Herc Holdings Inc. (HRI) common stock, representing 14.0% of the outstanding shares. The filing indicates that BlackRock's iShares Core S&P Small-Cap ETF holds more than 5% of Herc's common stock. BlackRock certifies the shares were acquired and are held in the ordinary course of business, not for changing or influencing control of the issuer.

• · BlackRock's beneficial ownership increased from a prior filing (this is an amendment, SC 13G/A), though the prior percentage is not disclosed in this filing.
• · BlackRock has sole voting power over 4,621,544 shares and sole dispositive power over all 4,675,626 shares, with no shared voting or dispositive power.
• · The filing is made pursuant to Rule 13d-1(b), indicating passive investment intent.
• · BlackRock certifies that the securities were not acquired to change or influence control of Herc Holdings.
• · The iShares Core S&P Small-Cap ETF, a BlackRock-managed fund, holds more than 5% of Herc's outstanding common stock.
• · The filing includes a power of attorney dated January 21, 2025, authorizing multiple individuals to execute regulatory filings on behalf of BlackRock.

05-10-2026

BlackRock, Inc. filed a Schedule 13G/A disclosing beneficial ownership of 24,923,503 shares of VIAVI SOLUTIONS INC. common stock as of September 30, 2026, representing 10.1% of the outstanding shares. The filing indicates no change in BlackRock's investment purpose—shares were acquired and are held in the ordinary course of business, not to influence control. This is an administrative update to an existing 13G filing, with no new material activity or change in BlackRock's position relative to any prior filing.

• · No prior ownership percentage was provided in this filing for comparison, but the 10.1% stake is unchanged from the previous 13G filing according to this submission (no change in beneficial ownership noted).
• · The filing includes a Power of Attorney dated January 21, 2025, appointing various officers to execute regulatory filings.
• · BlackRock Fund Advisors is specifically noted as beneficially owning 5% or greater of the outstanding shares.

05-10-2026

BlackRock, Inc. filed a Schedule 13G/A with the SEC on October 5, 2026, disclosing beneficial ownership of 1,506,921 common shares of AMERISAFE INC, representing 8.1% of the outstanding shares. The filing indicates that no single person's interest exceeds 5% of the total outstanding shares, and the securities were acquired in the ordinary course of business without the purpose of changing or influencing control of the issuer.

• · BlackRock holds sole voting power over 1,476,744 shares and sole dispositive power over 1,506,921 shares.
• · The filing is an amendment to a previous Schedule 13G, with a date of change of October 5, 2026.
• · BlackRock's business units listed in Exhibit 99 include entities such as BlackRock Fund Advisors and BlackRock Institutional Trust Company, National Association, with one entity noted as beneficially owning 5% or more of the class.

05-10-2026

BlackRock, Inc. filed an amended Schedule 13G with the SEC on October 5, 2026, reporting beneficial ownership of 7,837,484 shares of AtriCure, Inc. common stock, representing 15.4% of the outstanding shares. The filing is a routine disclosure of passive investment holdings and does not indicate any change in control intent.

• · BlackRock's filing is made under Rule 13d-1(b), indicating passive investment intent.
• · The filing includes a power of attorney dated January 21, 2025, authorizing multiple individuals to execute regulatory filings.
• · One of BlackRock's subsidiaries, BlackRock Fund Advisors, beneficially owns 5% or more of AtriCure's outstanding shares.
• · The iShares Core S&P Small-Cap ETF, managed by BlackRock, holds more than 5% of AtriCure's common stock.

05-10-2026

Wolverine Asset Management LLC and related entities filed a Schedule 13G/A disclosing they hold 0 Class A Ordinary Shares of Pono Capital Four, Inc., representing 0% beneficial ownership as of September 30, 2026. The filing indicates the group has no voting or dispositive power over any shares, meaning they have completely exited their position in the blank-check company.

• · The filing is an amendment (SCHEDULE 13G/A) filed on October 5, 2026, with a date of change of October 5, 2026.
• · The securities were acquired and are held in the ordinary course of business, not for changing or influencing control of the issuer.
• · Wolverine Asset Management is an investment adviser filing under Rule 13d-1(b).

05-10-2026

BlackRock, Inc. filed a Schedule 13G with the SEC on October 5, 2026, disclosing beneficial ownership of 60,766,830 shares of ONEOK Inc. common stock, representing a 9.6% stake. The filing reflects a passive investment held in the ordinary course of business, with no intent to change or influence control of the company.

• · The filing was made pursuant to Rule 13d-1(b) under the Securities Exchange Act of 1934, indicating passive investment intent.
• · BlackRock has sole voting power over 56,786,468 shares and sole dispositive power over 60,766,830 shares.
• · No single person's interest in the common stock exceeds 5% of the total outstanding shares.
• · BlackRock's Schedule 13G covers securities beneficially owned by certain designated business units, with other units' holdings disaggregated per SEC Release No. 34-39538.

05-10-2026

Wolverine Asset Management LLC and related entities filed a Schedule 13G/A disclosing beneficial ownership of 10,270 Class A Ordinary Shares of Andretti Acquisition Corp. II, representing 0.07% of outstanding shares as of September 8, 2026. The filing reflects a routine institutional ownership update with no change in control intent.

• · The filing is an amendment (SC 13G/A) filed on October 5, 2026, with an event date of September 8, 2026.
• · Wolverine Asset Management LLC is an investment adviser filing under Rule 13d-1(b).
• · Each reporting person has shared voting and dispositive power over 10,270 shares (not sole power).
• · The filing certifies the securities were acquired in the ordinary course of business and not to change or influence control of the issuer.

05-10-2026

SBI Digital Asset Holdings Co., Ltd., a wholly owned subsidiary of SBI Holdings, Inc., filed a Schedule 13G with the SEC on October 5, 2026, disclosing beneficial ownership of 15,308,819 Class A Common Shares of OBOOK HOLDINGS INC., representing 40.5% of the 37,825,411 shares outstanding as of May 14, 2026. The shares are held through SBI Digital Strategic Investment Co., Ltd., and were acquired prior to the issuer's Nasdaq listing. This filing is a routine disclosure of a major shareholding and does not indicate any change in ownership or intent to acquire control.

• · The shares were acquired prior to the issuer's listing on Nasdaq.
• · The filing is made under Rule 13d-1(d) of the Securities Exchange Act of 1934.
• · SBI Digital Asset Holdings is a wholly owned subsidiary of SBI Holdings, Inc.
• · The shares are held by SBI Digital Strategic Investment Co., Ltd., a wholly owned subsidiary of SBI Digital Asset Holdings.
• · The filing was signed on September 17, 2026.

05-10-2026

BlackRock Portfolio Management LLC filed an amended Schedule 13G with the SEC on October 5, 2026, disclosing beneficial ownership of 15,148,063 shares (37.5%) of iShares, Inc. common stock as of September 30, 2026. The filing is a routine disclosure of passive investment holdings, with no change in control intent. The reported ownership represents a significant stake, but the filing does not indicate any acquisition or disposal activity.

• · The filing is an amendment to a previous Schedule 13G, indicating a change in ownership details.
• · BlackRock Fund Advisors is identified as an entity that beneficially owns 5% or greater of the outstanding shares of the security class.
• · The filing includes a power of attorney dated July 1, 2025, revoking a prior power of attorney dated January 28, 2025.
• · The filing is made pursuant to Rule 13d-1(b), indicating passive investment intent.

05-10-2026

CIBC Private Wealth Group LLC filed a Schedule 13G/A with the SEC on October 5, 2026, disclosing that it has ceased to be the beneficial owner of more than 5% of Plains All American Pipeline LP's common units. The filing reports zero beneficial ownership (0 units, 0.0% class), indicating CIBC Private Wealth Group LLC has fully exited its position in the pipeline company.

• · The filing is an amendment to Schedule 13G, indicating a change in ownership from a prior filing.
• · CIBC Private Wealth Group LLC is filing under Rule 13d-1(b), which is used for institutional investors.
• · The filing date is October 5, 2026, with the reporting period ending December 31, 2024.
• · The filer's address is 3290 Northside Parkway, 7th Floor, Atlanta, GA 30327.
• · The issuer's address is 333 Clay Street, Suite 1600, Houston, TX 77002.

05-10-2026

Paradigm BioCapital Advisors LP and related entities disclosed a 6.6% beneficial ownership stake in Obsidian Therapeutics, Inc. (formerly Gazelle Parent, Inc.) as of September 28, 2026, holding 4,101,576 shares of common stock. The filing is a routine Schedule 13G filing by an institutional investment manager, indicating passive investment intent.

• · The filing is made under Rule 13d-1(c), indicating passive investment intent.
• · Paradigm BioCapital International Fund Ltd. directly owns 3,613,771 shares (5.9% of outstanding).
• · The remaining shares are held in separately managed accounts managed by the Adviser.
• · The issuer changed its name from Gazelle Parent, Inc. to Obsidian Therapeutics, Inc. on April 17, 2026.
• · The filing date is October 5, 2026, with the event date of September 28, 2026.

05-10-2026

BW Group Ltd filed Amendment No. 7 to its Schedule 13D, disclosing beneficial ownership of 4,059,078 common shares (6.60%) of Navigator Holdings Ltd. as of October 5, 2026. The filing reveals that BW Group sold 700,000 shares in open-market transactions between September 23 and October 1, 2026, at average prices ranging from $22.94 to $23.46 per share. This represents a reduction in BW Group's stake, though it remains a significant shareholder.

• · BW Group sold 100,000 shares on each of seven trading days from September 23 to October 1, 2026.
• · Sale price ranges per day: 23-Sep ($22.775-$23.52), 24-Sep ($22.74-$23.53), 25-Sep ($22.7996-$23.3021), 28-Sep ($22.74-$23.27), 29-Sep ($22.58-$23.14), 30-Sep ($23.03-$23.345), 01-Oct ($22.72-$23.80).
• · BW Group has sole voting and dispositive power over all 4,059,078 shares.
• · The filing is Amendment No. 7 to the original Schedule 13D filed on December 28, 2020.

05-10-2026

First National Advisers, LLC filed a Schedule 13G/A with the SEC on October 5, 2026, disclosing beneficial ownership of 865,344 shares of Goldman Sachs Data Enhanced International Equity ETF, a series of Goldman Sachs ETF Trust. The filing indicates an 82% ownership stake in the ETF, held in the ordinary course of business without intent to influence control.

• · The filing is an amendment (Schedule 13G/A) filed under Rule 13d-1(b), indicating passive investment intent.
• · First National Advisers, LLC is organized under Nebraska law and its business address is in Omaha, Nebraska.
• · The ETF's CUSIP is 38149W382.
• · The filing was signed by Brett Badalucco, Chief Compliance Officer of First National Advisers, LLC.

05-10-2026

Point72 Asset Management, L.P., along with its affiliates Point72 Capital Advisors, Inc. and Steven A. Cohen, disclosed a 5.2% beneficial ownership stake in E.W. Scripps Co as of October 2, 2026, holding 4,192,722 shares of Class A Common Stock. The filing is a routine Schedule 13G under Rule 13d-1(c), indicating the shares were acquired in the ordinary course of business and not with the intent to influence control. No prior period comparison is available as this is an initial filing.

• · The filing is made pursuant to Rule 13d-1(c), indicating passive investment intent.
• · Point72 Asset Management has investment and voting power over the shares held by Point72 Associates via an investment management agreement.
• · Point72 Capital Advisors, Inc. is the general partner of Point72 Asset Management.
• · Steven A. Cohen controls both Point72 Asset Management and Point72 Capital Advisors, Inc.
• · The reporting persons own no shares directly; all 4,192,722 shares are held indirectly through Point72 Associates.
• · The filing date is October 5, 2026, with beneficial ownership determined as of October 2, 2026.

05-10-2026

Biotechnology Value Fund L.P. and affiliated entities filed an amended Schedule 13G disclosing aggregate beneficial ownership of approximately 14.3% of Foghorn Therapeutics Inc. common stock as of October 1, 2026. The group holds 8,507,000 shares (including 160,832 shares in a managed account) and also holds pre-funded warrants and Series 1/2 warrants, all subject to blockers preventing exercise above 9.99% ownership. The filing confirms the holdings are not for control purposes.

• · Pre-Funded Warrants have an exercise price of $0.0001 per share, are exercisable immediately, and do not expire.
• · Series 1 Warrants have an exercise price of $13.42 per share, expire June 30, 2027.
• · Series 2 Warrants have an exercise price of $20.13 per share, expire December 31, 2030.
• · All warrants are subject to blockers that prohibit exercise if it would result in beneficial ownership exceeding 9.99% of outstanding shares.
• · The filing certifies that the securities were not acquired or held for the purpose of changing or influencing control of the issuer.

05-10-2026

CK Amarillo LP and related entities (Knighthead Capital Management, Certares Opportunities LLC) filed a Schedule 13D/A disclosing beneficial ownership of 181,455,469 shares of Hertz Global Holdings, Inc. common stock, representing 50.9% of the outstanding shares as of July 30, 2026. Effective October 1, 2026, Thomas Wagner resigned from Hertz's board of directors and was replaced by Adam Zirkin, both affiliated with Knighthead. The filing reflects a controlling stake with no change in ownership percentage from the prior filing.

• · This is Amendment No. 12 to the original Schedule 13D filed July 12, 2021
• · Thomas Wagner continues to serve on the investment committee of CK Amarillo after resigning from the board
• · The ownership percentage is based on 356,451,393 shares outstanding as of July 30, 2026 (Form 10-Q)
• · Filing date: October 5, 2026; effective date of board changes: October 1, 2026

05-10-2026

YA II PN, Ltd. and its affiliates (Yorkville Advisors entities and Mark Angelo) filed an amended Schedule 13G with the SEC on October 5, 2026, disclosing their beneficial ownership of Class A Common Stock in Beneficient (BENFW). The filing reports zero shares held by each reporting entity as of September 30, 2026, and includes a certification that the securities were not acquired to influence control of the issuer.

• · Filing is an amendment (Schedule 13G/A) to a previous beneficial ownership report.
• · All reporting entities reported 0.00 shares of Class A Common Stock owned as of September 30, 2026.
• · The filing certifies the shares were not acquired or held to change or influence control of Beneficient.
• · Mark Angelo is identified as the individual making investment decisions on behalf of YA II PN, Ltd.
• · The filing includes a complex chain of affiliated entities: YA II PN, Ltd. → YA Global Investments II (U.S.), LP (Feeder) → Yorkville Advisors Global, LP (Advisor) → Yorkville Advisors Global II, LLC (Advisor GP) → YAII GP, LP (GP) → YAII GP II, LLC (Yorkville GP).
• · SC-Sigma Global Partners, LP is noted as an investor in YA II PN, Ltd., with overlapping control through the same general partners and advisor.

05-10-2026

Pzena Investment Management LLC reported beneficial ownership of 1,785,166 shares of Varex Imaging Corp common stock, representing 4.2% of the outstanding class as of September 30, 2026. The filing states the securities were acquired and held in the ordinary course of business, without the purpose or effect of changing or influencing Varex Imaging’s control.

• · The Schedule 13G/A was filed on October 05, 2026, under Rule 13d-1(b).
• · The beneficial ownership position was reported as of September 30, 2026.
• · Pzena Investment Management LLC reported no shared voting power and no shared dispositive power.
• · The filing states that no individual client beneficially owns more than 5% of the class.
• · Clients of Pzena Investment Management LLC have the right to receive dividends or sale proceeds from the reported securities.
• · Pzena Investment Management LLC is organized in Delaware and listed its business address as 320 Park Avenue, 8th Floor, New York, NY 10022.

05-10-2026

YA II PN, Ltd. and related entities filed a Schedule 13G/A disclosing beneficial ownership of 173,000 shares of Optimi Health Corp. common stock, representing 3.0% of the outstanding shares as of September 30, 2026. The filing indicates no change in the number of shares owned compared to the prior filing, and the group certifies the shares were not acquired to influence control.

• · The filing is an amendment (Schedule 13G/A) filed under Rule 13d-1(c).
• · All reporting persons disclaim beneficial ownership except to the extent of their pecuniary interest.
• · The filing certifies the securities were not acquired to change or influence control of the issuer.